PhaseBio Pharmaceuticals Inc. (PHAS) Prices 16M Share Common Offering at $3.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
PhaseBio Pharmaceuticals Inc. (PHAS) to Offer Common Stock
March 17, 2021 5:02 PM EDTPhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS) announced that it has commenced an underwritten public offering of shares of its common stock. In addition, PhaseBio expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. All of... More
PhaseBio Pharmaceuticals Inc. (PHAS) PT Raised to 'Street High' $19 at Needham & Company
March 16, 2021 10:44 AM EDTNeedham & Company analyst Chad Messer raised the price target on PhaseBio Pharmaceuticals Inc. (NASDAQ: PHAS) a 'Street High' to $19.00 (from $18.00) while maintaining a Buy rating.
... MorePhaseBio Pharmaceuticals Inc. (PHAS) Halted on LUDP, Up 12%
March 16, 2021 10:42 AM EDTPhaseBio Pharmaceuticals Inc. (NASDAQ: PHAS) Halted on LUDP, Up 12%
